Patent Bear/Proceedings/IPR2024-00631
IPRIPR2024-00631Terminated-Settled

Apotex Inc. et al.v.Novo Nordisk A/S

IPR challenge of US 10335462.

Type
IPR
Filed
Mar 1, 2024
Instituted
Sep 11, 2024
Decided
Jan 10, 2025
Patent
Application
15656042
Inventor
Christine Bjoern Jensen
Granted
Jul 2, 2019
01

Timeline

3 milestones
2024-03-01Petition filed
2024-09-11Institution
2025-01-10Terminated
02

Parties & counsel

Petitioner
Apotex Inc. et al.
Counsel
Molenda, Johnet al
Patent Owner
Novo Nordisk A/S
Counsel
Baughman, Jonet al
03

Docket

Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.

SOURCE · USPTO PTAB E2EView on Unified Patents →